InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by VINCENT RICHARD G, Chief Financial Officer. Officer active across 1 companies, notably Oncternal Therapeutics, Inc.. In total, 5 filings have been logged. Total volume traded: €16k. The latest transaction was filed on 24 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
€43 shares@ €1.31740.0% of flow
Common Stock
SEC:0001209191-22-021302:0·
Ideal exit: 19 Dec 2022 (T+270)
€8,0055,000 shares@ €1.600950.0% of flow
Common Stock
SEC:0001209191-22-005559:0·
Ideal exit: 24 Oct 2022 (T+270)
€8,0055,000 shares@ €1.6009100.0% of flow
Common Stock
SEC:0001209191-22-005559·
Ideal exit: 24 Oct 2022 (T+270)
029,867 shares0
Common Stock
SEC:0001209191-22-001971·
029,867 shares0
Common Stock
SEC:0001209191-22-001971:0·
5 of 5 declarations
About VINCENT RICHARD G
Richard G. Vincent is Chief Financial Officer at Oncternal Therapeutics, Inc. He manages the company's finances, overseeing financial reporting and budgeting strategy. His role is crucial for ensuring financial transparency and regulatory compliance at Oncternal Therapeutics.
